Skip to main content
Clinical Trials/NCT04037982
NCT04037982UnknownNot Applicable

A Randomized Controlled Study on the Safety of Total Laparoscopy and Traditional Open Pancreaticoduodenectomy in the Treatment of Periampullary Tumors

Beijing Friendship Hospital1 site in 1 country102 target enrollmentStarted: August 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
102
Locations
1
Primary Endpoint
Incidence of complications

Study Overview

Brief Summary

Pancreaticoduodenectomy (PD) is considered one of the most complex and dangerous procedures in general surgery. This procedure is the preferred surgical procedure for treating tumors around the ampulla. Traditional open pancreaticoduodenectomy (OPD) has brought great surgical trauma to patients while treating diseases. In 1994, Gagner et al first reported laparoscopic pancreaticoduodenectomy (LPD). With the development of laparoscopic techniques, the updating of devices, and the continuous accumulation of laparoscopic gastrointestinal surgery experience, the results of retrospective studies published show that there is no significant difference in safety between LPD and OPD. However, the results of the recently published RCT study show that the mortality associated with LPD complications is five times greater than that of OPD. At present, the security of LPD has been controversial. Therefore we conducted a prospective randomized controlled trial with a primary outcome of perioperative complications, providing evidence-based results for the safe and effective clinical development of LPD.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Preoperative imaging diagnosis of periampullary tumor, or preoperative pathological diagnosis of periampullary tumor, preoperative evaluation can be performed pancreaticoduodenectomy; Serum bilirubin was less than 100 μ mol/L before operation; Sign a written informed consent form and agree to be randomly divided into groups for surgical treatment.

Exclusion Criteria

  • Not provided

Arms & Interventions

LPD

Experimental

In this group, patients will undergo laparoscopic pancreaticoduodenectomy.

Intervention: laparoscopic pancreaticoduodenectomy (Procedure)

OPD

Active Comparator

In this group, patients will undergo open pancreaticoduodenectomy.

Intervention: Open pancreaticoduodenectomy (Procedure)

Outcomes

Primary Outcomes

Incidence of complications

Time Frame: 30 days after operation

The patients number with complications / The total number in this group

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zhongtao Zhang

Chief Physician

Beijing Friendship Hospital

Study Sites (1)

Loading locations...

Similar Trials

RCT Study on Safety of LPD and OPD in the... | Clinical Trial